FIND Diagnostics

Geneve, Switzerland Founded: 2003 • Age: 23 yrs
Diagnostic tests for poverty-related diseases
Annual revenue $10.9M Latest available
Total funding - 3 rounds
Employees 97 Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About FIND Diagnostics

FIND Diagnostics is a company based in Geneve (Switzerland) founded in 2003. The company has 97 employees as of April 10, 2024. FIND Diagnostics operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.

  • Headquarter Geneve, Switzerland
  • Employees 97 as on 10 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Foundation For Innovative New Diagnostics India
  • Date of Incorporation 07 Jul, 2015
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $10.91 M (USD)
    -39.99
    as on Mar 31, 2023
  • Net Profit
    -$45.33 K (USD)
    -3528.38
    as on Mar 31, 2023
  • EBITDA
    -$10.9 M (USD)
    39.9
    as on Mar 31, 2023
  • Latest Funding Round
    $27.34 K (USD), Grant

    Oct 01, 2022

  • Investors
    HHS

    & 1 more

  • Employee Count
    97

    as on Apr 10, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of FIND Diagnostics

Investors in FIND Diagnostics

FIND Diagnostics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Premium access

Investor details for FIND Diagnostics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by FIND Diagnostics

Investments
Premium access

Investment portfolio details for FIND Diagnostics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - FIND Diagnostics

Premium access

Detailed financials for FIND Diagnostics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Find Diagnostics Comparisons

FIND Diagnostics Primary company
Description
Diagnostic tests for poverty-related diseases
Location
Geneve, Switzerland
Founded Year
2003
Annual Revenue
$10.91 M (USD)
Net Profit
-$45.33 K (USD)
EBITDA
-$10.9 M (USD)
Employees
97
As of 2024
Premium access

Peer comparison for FIND Diagnostics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of FIND Diagnostics

FIND Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of diagnostic solutions for systemic infections
Locked Locked Locked
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
Locked Locked Locked
Provider of machine learning based diagnostic solutions for infectious diseases
Locked Locked Locked
Portable PCR diagnostics for infectious diseases are developed.
Locked Locked Locked
Instruments and test panels for multiplexed molecular diagnostics are provided.
Locked Locked Locked
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
Premium access

Detailed competitors of FIND Diagnostics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Find Diagnostics

Premium access

Complete news archive for FIND Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FIND Diagnostics

FIND Diagnostics was founded in 2003 and raised its 1st funding round 7 years after it was founded.

FIND Diagnostics is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.

William Rodriguez is the current CEO of FIND Diagnostics.

As of Apr 10, 2024, the latest employee count at FIND Diagnostics is 97.

Annual revenue of FIND Diagnostics is $10.91M as on Mar 31, 2023.

FIND is a global non-profit organization engaged in the development, evaluation, and delivery of high-quality, affordable diagnostic tests for poverty-related diseases, including TB, malaria, HIVAIDS, sleeping sickness, hepatitis C, Chagas disease, etc., as well as infectious diseases with outbreak potential, such as Ebola. FIND operates as a product development partnership with active collaborations with over 150 organizations including government ministries, academic centers, commercial entities, NGOs and PPPs. Intellectual property developed and owned by FIND is commercialized in partnership with commercial entities in a manner that ensures that benefits are passed on to patients in resource-poor settings, while distribution rights for high-income countries and the private sector in developing countries are retained by the industry partner.

FIND Diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.

FIND Diagnostics has 2 investors. Key investors include HHS, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available